Endo Pharmaceuticals Holdings (ENDP) Tops Q4 EPS by 7c, Reaffirms Outlook
Get Alerts ENDP Hot Sheet
Price: $0.29 --0%
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
SHIM, KOD, HEWA, More
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q4 EPS of $1.62, $0.07 better than the analyst estimate of $1.55. Revenue for the quarter came in at $801.1 million versus the consensus estimate of $807.98 million. Endo Pharmaceuticals Holdings reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Endo Pharmaceuticals Holdings (ENDP) click here.
For earnings history and earnings-related data on Endo Pharmaceuticals Holdings (ENDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Cleveland-Cliffs (CLF) lifted to buy at GLJ Research as it looks like 'smooth sailing' ahead
- Shimmick Corporation (SHIM) Misses Q4 EPS by 38c ; Provides Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!